181 related articles for article (PubMed ID: 36547230)
1. GATA3 Encapsulated by Tumor-Associated Macrophage-Derived Extracellular Vesicles Promotes Immune Escape and Chemotherapy Resistance of Ovarian Cancer Cells by Upregulating the CD24/Siglec-10 Axis.
Chen C; Zhang L; Ruan Z
Mol Pharm; 2023 Feb; 20(2):971-986. PubMed ID: 36547230
[TBL] [Abstract][Full Text] [Related]
2. Extracellular vesicles derived from M2-polarized tumor-associated macrophages promote immune escape in ovarian cancer through NEAT1/miR-101-3p/ZEB1/PD-L1 axis.
Yin L; Wang Y
Cancer Immunol Immunother; 2023 Mar; 72(3):743-758. PubMed ID: 36319716
[TBL] [Abstract][Full Text] [Related]
3. Delivery of SIRT1 by cancer-associated adipocyte-derived extracellular vesicles regulates immune response and tumorigenesis of ovarian cancer cells.
Zheng Q; Du X; Zhang J; Liu Y; Dong W; Dai X; Gu D
Clin Transl Oncol; 2024 Jan; 26(1):190-203. PubMed ID: 37311988
[TBL] [Abstract][Full Text] [Related]
4. The biological roles of CD24 in ovarian cancer: old story, but new tales.
Gu Y; Zhou G; Tang X; Shen F; Ding J; Hua K
Front Immunol; 2023; 14():1183285. PubMed ID: 37359556
[TBL] [Abstract][Full Text] [Related]
5. LncRNA IL21-AS1 facilitates tumour progression by enhancing CD24-induced phagocytosis inhibition and tumorigenesis in ovarian cancer.
Liu J; Yan C; Xu S
Cell Death Dis; 2024 May; 15(5):313. PubMed ID: 38702326
[TBL] [Abstract][Full Text] [Related]
6. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy.
Barkal AA; Brewer RE; Markovic M; Kowarsky M; Barkal SA; Zaro BW; Krishnan V; Hatakeyama J; Dorigo O; Barkal LJ; Weissman IL
Nature; 2019 Aug; 572(7769):392-396. PubMed ID: 31367043
[TBL] [Abstract][Full Text] [Related]
7. TAM-derived extracellular vesicles containing microRNA-29a-3p explain the deterioration of ovarian cancer.
Lu L; Ling W; Ruan Z
Mol Ther Nucleic Acids; 2021 Sep; 25():468-482. PubMed ID: 34589270
[TBL] [Abstract][Full Text] [Related]
8. GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma.
El-Arabey AA; Denizli M; Kanlikilicer P; Bayraktar R; Ivan C; Rashed M; Kabil N; Ozpolat B; Calin GA; Salama SA; Abd-Allah AR; Sood AK; Lopez-Berestein G
Cell Signal; 2020 Apr; 68():109539. PubMed ID: 31935430
[TBL] [Abstract][Full Text] [Related]
9. CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder.
Wang X; Liu M; Zhang J; Brown NK; Zhang P; Zhang Y; Liu H; Du X; Wu W; Devenport M; Tao W; Mao-Draayer Y; Chen GY; Chen YE; Zheng P; Liu Y
Cell Metab; 2022 Aug; 34(8):1088-1103.e6. PubMed ID: 35921817
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a novel dual-targeting D-peptide to block CD24/Siglec-10 and PD-1/PD-L1 interaction and synergize with radiotherapy for cancer immunotherapy.
Shen W; Shi P; Dong Q; Zhou X; Chen C; Sui X; Tian W; Zhu X; Wang X; Jin S; Wu Y; Chen G; Qiu L; Zhai W; Gao Y
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37344099
[TBL] [Abstract][Full Text] [Related]
11. Siglec-G-CD24 axis controls the severity of graft-versus-host disease in mice.
Toubai T; Hou G; Mathewson N; Liu C; Wang Y; Oravecz-Wilson K; Cummings E; Rossi C; Evers R; Sun Y; Wu J; Choi SW; Fang D; Zheng P; Liu Y; Reddy P
Blood; 2014 May; 123(22):3512-23. PubMed ID: 24695850
[TBL] [Abstract][Full Text] [Related]
12. miR-106a-5p carried by tumor-derived extracellular vesicles promotes the invasion and metastasis of ovarian cancer by targeting KLF6.
Zheng Y; Zhu K; Wang G
Clin Exp Metastasis; 2022 Aug; 39(4):603-621. PubMed ID: 35449340
[TBL] [Abstract][Full Text] [Related]
13. Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal/GalNAc epitopes elicit anti-tumor immunity.
Huang J; Li M; Mei B; Li J; Zhu Y; Guo Q; Huang J; Zhang G
J Transl Med; 2022 Oct; 20(1):496. PubMed ID: 36316782
[TBL] [Abstract][Full Text] [Related]
14. Novel insights into the function of CD24: A driving force in cancer.
Altevogt P; Sammar M; Hüser L; Kristiansen G
Int J Cancer; 2021 Feb; 148(3):546-559. PubMed ID: 32790899
[TBL] [Abstract][Full Text] [Related]
15. Kynurenine in IDO1
Ying X; Zheng X; Zhang X; Yin Y; Wang X
J Transl Med; 2024 Mar; 22(1):267. PubMed ID: 38468343
[TBL] [Abstract][Full Text] [Related]
16. Targeting CD24/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions.
Li X; Tian W; Jiang Z; Song Y; Leng X; Yu J
Cancer Immunol Immunother; 2024 Jan; 73(2):31. PubMed ID: 38279998
[TBL] [Abstract][Full Text] [Related]
17. Extracellular vesicle-packaged miR-181c-5p from epithelial ovarian cancer cells promotes M2 polarization of tumor-associated macrophages via the KAT2B/HOXA10 axis.
Yang S; Zhao H; Xiao W; Shao L; Zhao C; Sun P
J Gene Med; 2022 Oct; 24(10):e3446. PubMed ID: 36027869
[TBL] [Abstract][Full Text] [Related]
18. Malignant ascite-derived extracellular vesicles inhibit T cell activity by upregulating Siglec-10 expression.
Li Y; Zhou J; Zhuo Q; Zhang J; Xie J; Han S; Zhao S
Cancer Manag Res; 2019; 11():7123-7134. PubMed ID: 31534365
[No Abstract] [Full Text] [Related]
19. Siglec-9
Wang Y; He M; Zhang C; Cao K; Zhang G; Yang M; Huang Y; Jiang W; Liu H
J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37709296
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD24 and Siglec-10 in first trimester placenta: implications for immune tolerance at the fetal-maternal interface.
Sammar M; Siwetz M; Meiri H; Fleming V; Altevogt P; Huppertz B
Histochem Cell Biol; 2017 May; 147(5):565-574. PubMed ID: 28012129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
